Eli Lilly putting $400M into US diabetes med production
31 biopharmas at high risk of bankruptcy
Sackler family thriving with oxytocin sales in China through Mundipharma
Bristol-Myers misses main goal of advanced melanoma trial
*please scroll down for all the latest news*
Want to stay updated on CP happenings? New features, new boards, CP wire articles, and more? Click here to subscribe
